Komori
Financial Results Presentation7061Japan Hospice Holdings Inc.Information and Communications, Services and Others

FAQ on Financial Results for the First Quarter of the Fiscal Year Ending December 2026

The company explained that first-quarter revenue and earnings for the fiscal year ending December 2026 are progressing in line with its plan. However, revenue per user is expected to decline by approximately 15% due to the revision to the medical fee schedule, which may adversely affect earnings in the short term. The company indicated that it plans to address this by improving productivity through optimizing staffing levels.

Worth reading
55In focus
Scored from 5 of 6 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
15
% (decline in revenue per user)
Wording
Avoiding a definitive answer
How definitive the wording is.

Contents of this document

Summary of Q&AFirst quarter of the fiscal year ending December 202611 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Results for the three months of the current quarterRevenue and earnings were broadly in line with the plan. Specific actual amounts: Not disclosed
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Both revenue and earnings were broadly in line with the plan
Key points of the Q&AKey questions raised by investors at the briefing and the company's answers
Impact of the medical fee schedule revision: revenue per user is expected to decline by approximately 15%, but productivity will be improved by optimizing staffing levels / First-quarter progress: revenue and earnings were broadly in line with the plan / Business plan from 2027 onward: the timing of disclosure is undecided because the plan will be prepared after assessing conditions following the medical fee schedule revision / Impact of interest rate increases: most interest expense consists of accounting amounts associated with finance leases, so the impact is limited / Partnership with Sugi Holdings: 7 facilities have been co-developed, with approximately 10 more under discussion / Equity financing: equity financing is not needed in the short term, while the medium- to long-term decision will be based on a comprehensive assessment / Transfer to the Prime Market: specific timing is under consideration / Hiring: there have been many applicants, and no facility opening has ever been delayed due to hiring / Facility opening model: approximately 90% of all facilities are operated under leases / Becoming profitable: the plan is for 30-room facilities to achieve monthly profitability in 6 months and cumulative profitability in 12 months, and for 40-room facilities to achieve monthly profitability in 8 months and cumulative profitability in 18 months
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Revenue per user: approximately 15% decline (impact of the 2026 medical fee schedule revision) / Medical staff and facilities: decrease, improving productivity / 4 facilities opened at the end of the previous year: increased operating losses
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Impact of the 2026 medical fee schedule revision / Business earnings over the several months following June 2026 / Optimization of facility staffing levels by year-end / Facility development plans from 2027 onward: undecided
New initiatives
Selecting bundled home-visit nursing services following the medical fee schedule revision and optimizing facility staffing levels / Collaboration with Sugi Holdings to raise awareness, co-develop facilities and improve the quality of palliative care / Expanding co-developed facilities / Monetizing company-owned properties through sale-and-leaseback transactions
Key KPIsA metric the company considers important as a management benchmark.
Revenue per user: approximately 15% decline, including an 8% decline in the second half of the previous fiscal year alone / Utilization: increased in line with the plan / Co-developed facilities: 7 / Facilities under discussion for development from 2026 onward: approximately 10 / Proportion of facilities operated under leases: approximately 90%
Unit price and quantity metricsThese figures show sales broken down by price and volume.
Revenue per user: approximately 15% decline, including an 8% decline in the second half of the previous fiscal year alone / Utilization: increased in line with the plan (specific figure: Not disclosed)
Medium-term management plan targets
Assuming the previous medium-term management plan, the company is expected to meet the requirements for the Prime Market, including the net assets and profit thresholds, in 2026–2027. Specific targets under the medium-term management plan: Not disclosed
Financial targets
The company plans to improve the soundness of financial metrics, including the equity ratio. Numerical targets and actual figures: Not disclosed
Number of stores and locations
Approximately 90% of all facilities are operated under leases. 7 facilities have been co-developed with Sugi Holdings, with approximately 10 more under discussion. Total facilities at period-end and the number of facilities opened and closed during the period: Not disclosed
Number of employees
There were very many applicants for nursing and care staff positions relative to the number of openings. Number of employees, changes during the period and number of hires: Not disclosed
Contents of this document
ItemDetails
Document typeSummary of Q&A
Fiscal Period CoveredFirst quarter of the fiscal year ending December 2026
Results for the three months of the current quarterRevenue and earnings were broadly in line with the plan. Specific actual amounts: Not disclosed
Self-assessment against the planBoth revenue and earnings were broadly in line with the plan
Breakdown of Factors Affecting the ChangeRevenue per user: approximately 15% decline (impact of the 2026 medical fee schedule revision) / Medical staff and facilities: decrease, improving productivity / 4 facilities opened at the end of the previous year: increased operating losses
Key KPIsRevenue per user: approximately 15% decline, including an 8% decline in the second half of the previous fiscal year alone / Utilization: increased in line with the plan / Co-developed facilities: 7 / Facilities under discussion for development from 2026 onward: approximately 10 / Proportion of facilities operated under leases: approximately 90%
Unit price and quantity metricsRevenue per user: approximately 15% decline, including an 8% decline in the second half of the previous fiscal year alone / Utilization: increased in line with the plan (specific figure: Not disclosed)
Number of stores and locationsApproximately 90% of all facilities are operated under leases. 7 facilities have been co-developed with Sugi Holdings, with approximately 10 more under discussion. Total facilities at period-end and the number of facilities opened and closed during the period: Not disclosed
Number of employeesThere were very many applicants for nursing and care staff positions relative to the number of openings. Number of employees, changes during the period and number of hires: Not disclosed
Assumptions Underlying the Business OutlookImpact of the 2026 medical fee schedule revision / Business earnings over the several months following June 2026 / Optimization of facility staffing levels by year-end / Facility development plans from 2027 onward: undecided
Medium-term management plan targetsAssuming the previous medium-term management plan, the company is expected to meet the requirements for the Prime Market, including the net assets and profit thresholds, in 2026–2027. Specific targets under the medium-term management plan: Not disclosed
Financial targetsThe company plans to improve the soundness of financial metrics, including the equity ratio. Numerical targets and actual figures: Not disclosed
Key points of the Q&AImpact of the medical fee schedule revision: revenue per user is expected to decline by approximately 15%, but productivity will be improved by optimizing staffing levels / First-quarter progress: revenue and earnings were broadly in line with the plan / Business plan from 2027 onward: the timing of disclosure is undecided because the plan will be prepared after assessing conditions following the medical fee schedule revision / Impact of interest rate increases: most interest expense consists of accounting amounts associated with finance leases, so the impact is limited / Partnership with Sugi Holdings: 7 facilities have been co-developed, with approximately 10 more under discussion / Equity financing: equity financing is not needed in the short term, while the medium- to long-term decision will be based on a comprehensive assessment / Transfer to the Prime Market: specific timing is under consideration / Hiring: there have been many applicants, and no facility opening has ever been delayed due to hiring / Facility opening model: approximately 90% of all facilities are operated under leases / Becoming profitable: the plan is for 30-room facilities to achieve monthly profitability in 6 months and cumulative profitability in 12 months, and for 40-room facilities to achieve monthly profitability in 8 months and cumulative profitability in 18 months
New initiativesSelecting bundled home-visit nursing services following the medical fee schedule revision and optimizing facility staffing levels / Collaboration with Sugi Holdings to raise awareness, co-develop facilities and improve the quality of palliative care / Expanding co-developed facilities / Monetizing company-owned properties through sale-and-leaseback transactions
Items this document does not state (17)
Net SalesOperating profitOrdinary incomeNet incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesFull-year earnings forecastProgress against full-year forecastSegment resultsRisk amount incorporated into the outlookAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / Share

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Although revenue per user is expected to decline due to the revision to the medical fee schedule, selecting bundled home-visit nursing services will enable the company to bill for shorter visits, allowing it to reduce the number of medical staff and improve productivity. As for first-quarter earnings, operating losses at the 4 facilities opened at the end of the previous year increased, but business earnings, revenue per user and utilization were broadly in line with the plan.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
FAQ on Financial Results for the First Quarter of the Fiscal Year Ending December 2026 | Japan Hospice Holdings Inc. (7061) timely disclosure | Komori